ArticleBiomedicines2021

The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose.

Fabio Fiorino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.